Skip to main contentSkip to main content
Updating results

Evidence

  • Updated

MONDAY, Dec. 19, 2022 (HealthDay News) -- From July to December 2019 to July to December 2021, there was an increase in overdose deaths and deaths involving illicitly manufactured fentanyls (IMFs), according to research published in the Dec. 16 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

TUESDAY, Dec. 13, 2022 (HealthDay News) -- The U.S. Preventive Services Task Force (USPSTF) recommends preexposure prophylaxis (PrEP) for reducing the risk for HIV infection among individuals at increased risk for HIV acquisition. This recommendation forms the basis of a draft recommendation statement published online Dec. 13.

TUESDAY, Nov. 22, 2022 (HealthDay News) -- The U.S. Preventive Services Task Force (USPSTF) recommends screening for latent tuberculosis infection (LTBI) in populations at increased risk. This recommendation forms the basis of a draft recommendation statement, published online Nov. 22 by the USPSTF.

  • Updated

TUESDAY, Nov. 15, 2022 (HealthDay News) -- The U.S. Preventive Services Task Force (USPSTF) concludes that the current evidence is insufficient to recommend screening for obstructive sleep apnea (OSA) in the general adult population. These findings form the basis of a final recommendation statement published in the Nov. 15 issue of the Journal of the American Medical Association.

  • Updated

TUESDAY, Nov. 1, 2022 (HealthDay News) -- The U.S. Preventive Services Task Force (USPSTF) recommends against use of combined estrogen and progestin, or use of estrogen alone in those who have had a hysterectomy, for primary prevention of chronic conditions in postmenopausal persons. These recommendations form the basis of a final recommendation statement published in the Nov. 1 issue of the Journal of the American Medical Association.

Get up-to-the-minute news sent straight to your device.

Topics

Breaking News

News Alert